Treatment for Symptomatic Relief of Severe Tricuspid Regurgitation

Immediate Medical Management for Symptom Relief

Diuretics are essential as first-line therapy to manage volume overload, reduce right-sided heart failure symptoms, and provide symptomatic relief while preparing for definitive surgical intervention, as recommended by the American College of Cardiology 1, 2
Loop diuretics should be titrated to relieve systemic venous congestion, hepatic congestion, and peripheral edema that characterize symptomatic severe TR, according to the American College of Cardiology 1
Medical therapies to reduce pulmonary artery pressures might be considered in patients with severe functional TR and pulmonary hypertension, though evidence is limited (Class IIb recommendation), as stated by the American College of Cardiology 3, 4

The American College of Cardiology/American Heart Association strongly recommends (Class I) tricuspid valve surgery for patients with severe TR at the time of left-sided valve surgery 3, 4, 5
Combined mitral valve repair/replacement AND aortic valve repair/replacement with concomitant tricuspid valve repair is the recommended approach, as the moderate aortic and mitral regurgitation are driving the pulmonary hypertension that causes the functional TR, according to the American College of Cardiology 1
Tricuspid valve repair with annuloplasty is preferred over replacement when technically feasible, as recommended by the American College of Cardiology 1, 2

Comprehensive transthoracic echocardiography must evaluate valve anatomy, severity of all three valve lesions, chamber sizes, RV function, and estimate pulmonary artery pressure, as recommended by the American College of Cardiology 1, 3, 4
Invasive measurement of pulmonary artery pressures and pulmonary vascular resistance is useful when clinical and noninvasive data are discordant, as stated by the American College of Cardiology 3, 4
Assessment of RV function is critical, as severe RV dysfunction increases surgical risk and impacts long-term outcomes, according to the American College of Cardiology 1

Do not delay surgical referral while attempting prolonged medical management alone—the presence of symptomatic severe TR with left-sided valve disease warrants surgical evaluation, as recommended by the American College of Cardiology 1, 6
Do not perform isolated left-sided valve surgery without addressing the severe TR, as this increases the risk of requiring high-risk reoperation later, according to the American College of Cardiology 6

Continued medical therapy for pulmonary arterial hypertension is often necessary after valve surgery, as pulmonary hypertension may not completely resolve despite correction of valvular lesions, as stated by the American College of Cardiology 1
Regular follow-up with echocardiography is essential to monitor valve function, ventricular remodeling, and pulmonary pressures, according to the American College of Cardiology 1

Conservative management is recommended in symptomatic patients with severe secondary TR who have either severe RV dysfunction or irreversible pulmonary hypertension, in whom surgery or transcatheter intervention is highly likely to be futile, as recommended by the European Society of Cardiology 7
Reoperation for isolated TR may be considered only in patients who have undergone previous left-sided valve surgery and who do NOT have severe pulmonary hypertension or significant RV systolic dysfunction (Class IIb), according to the American College of Cardiology 3, 4, 6